TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting : vimarsana.com

TriSalus Life Sciences® Inc., , an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced...

Related Keywords

California , United States , Texas , San Diego , Chandrac Ghosh , Sapanp Patel , Michaels Lee , , Twitter , University Of Texas Md Anderson Cancer Center , Nasdaq , Trisalus Life Sciences , Linkedin , Uveal Melanoma Program , Society For Immunotherapy Of Cancer , Exchange Commission , Trisalus Life , Annual Meeting , Breaker Oral Presentation , Clinical Activity , Immune Checkpoint Inhibition , Metastatic Uveal Melanoma Liver Metastasis , Late Breaking Abstract Session , Poster Hall , Pressure Enabled Intrapancreatic Delivery , Checkpoint Blockade , Locally Advanced Pancreatic Adenocarcinoma , Initial Safety , Feasibility Experience , Associate Professor , Subcutaneously Enhances , Anti Tumor Immunity , Pressure Enabled Drug Delivery , Treating Liver Metastasis , Infusion System , Pancreatic Retrograde Venous Infusion System , Pressure Enabled Regional Immuno Oncology , Private Securities Litigation Reform Act , Markets ,